PNC Financial Services Group
EIGR

PNC Financial Services Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

PNC Financial Services Group’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7
Closed -$4K – 4719
2015
Q2 		$4K Sell
7
-2
-22% -$5.54K ﹤0.01% 4193
2015
Q1 		$79K Buy
9
+4
+80% +$35K ﹤0.01% 2818
2014
Q4 		$48K Buy
5
+4
+400% +$23.2K ﹤0.01% 2807
2014
Q3 		$5K Buy
+1
New +$5.28K ﹤0.01% 3466

Other funds holding EIGR

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PNC Financial Services Group's EIGR Position: Q3 2015 in Review

PNC Financial Services Group sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q3 2015, closing a stake of 7 shares — an estimated $4K sold.

PNC Financial Services Group first reported a position in EIGR in Q3 2014 and held it in 4 quarters. The position peaked at $79K in Q1 2015. 41 funds tracked by Wall St. Rank hold EIGR as of Q3 2015.

  • PNC Financial Services Group reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • PNC Financial Services Group sold 7 Eiger BioPharmaceuticals, Inc. shares in Q3 2015, an estimated $4K.
  • PNC Financial Services Group first reported a position in Eiger BioPharmaceuticals, Inc. in Q3 2014 and held it in 4 quarters.
  • PNC Financial Services Group's Eiger BioPharmaceuticals, Inc. position peaked at $79K in Q1 2015.
  • 41 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q3 2015.

Based on PNC Financial Services Group's 13F filing for Q3 2015, filed 6 Nov 2015.